Details for New Drug Application (NDA): 009053
✉ Email this page to a colleague
NDA 009053 describes PURINETHOL, which is a drug marketed by Stason Pharms and is included in one NDA. Additional details are available on the PURINETHOL profile page.
The generic ingredient in PURINETHOL is mercaptopurine. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mercaptopurine profile page.
The generic ingredient in PURINETHOL is mercaptopurine. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mercaptopurine profile page.
Summary for 009053
| Tradename: | PURINETHOL |
| Applicant: | Stason Pharms |
| Ingredient: | mercaptopurine |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
